We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Dismisses Abbvie Petition, Considers Others for Biosimilar Labeling Guidance
FDA Dismisses Abbvie Petition, Considers Others for Biosimilar Labeling Guidance
The FDA has shot down three citizen petitions seeking agency action on biosimilar labeling, arguing that a draft guidance issued in April is sufficient to address most of their concerns.